Identifying drug-drug interactions (DDIs) is a critical enabler for reducing adverse drug events and improving patient safety. Generating proper DDI alerts during prescribing workflow has the potential to prevent DDI-related adverse events. However, the implementation of DDI alerting system remains a challenge as users are experiencing alert overload, which causes alert fatigue. One strategy to optimize the current system is to establish a list of high-priority DDIs for alerting purposes, though it is a resource-intensive task. In this study, we propose a machine learning framework to extract useful features from the FDA adverse event reports and then identify potential high-priority DDIs using an autoencoder-based semi-supervised learning algorithm. The experimental results demonstrate the effectiveness of using adverse event feature representations in differentiating high- and low-priority DDIs. Additionally, the proposed algorithm utilizes stacked autoencoders and weighted support vector machine for boosting classification performance, which outperforms other competing methods in terms of F-measure and AUC score. This framework integrates multiple information sources, leverages domain knowledge and clinical evidence, and provides a practical approach for pre-screening high-priority DDI candidates for medication alerts.
1 August 2018 in Chaos: An Interdisciplinary Journal of Nonlinear Science
Nonlinear dynamical systems exhibit complex recurrence behaviors. Recurrence plot is widely used to graphically represent the patterns of recurrence dynamics and further facilitates the quantification of recurrence patterns, namely, recurrence quantification analysis. However, traditional recurrence methods tend to be limited in their ability to handle spatial data due to high dimensionality and geometric characteristics. Prior efforts have been made to generalize the recurrence plot to a four-dimensional space for spatial data analysis, but this framework can only provide graphical visualization of recurrence patterns in the projected reduced-dimension space (i.e., two- or three- dimensions). In this paper, we propose a new weighted recurrence network approach for spatial data analysis. A weighted network model is introduced to represent the recurrence patterns in spatial data, which account for both pixel intensities and spatial distance simultaneously. Note that each network node represents a location in the high-dimensional spatial data. Network edges and weights preserve complex spatial structures and recurrence patterns. Network representation is shown to be an effective means to provide a complete picture of recurrence patterns in the spatial data. Furthermore, we leverage network statistics to characterize and quantify recurrence properties and features in the spatial data. Experimental results in both simulation and real-world case studies show that the generalized recurrence network approach yields superior performance in the visualization of recurrence patterns in spatial data and in the extraction of salient features to characterize recurrence dynamics in spatial systems.
22 December 2006 in International Journal of Production Research
As a semiconductor supply chain becomes widespread and the competition pressure is very fierce, the detrimental effects of increasing varieties and variations are magnified in the supply chain. But many important issues, such as different service priorities, adaptability, controllability and scalability of performance metrics, have not been addressed in the literature. Conventional modelling techniques of supply chain operations are no longer effective for supply chain configuration. Therefore, a proposed empirical model was first built to catch up the relationship between supply-chain configuration and metrics under the influence of the variability sources. Next, an optimal supply chain configuration model is formulated as a polynomial goal programming model to accommodate different goal objectives. Finally, an efficient solution methodology is further developed to find out the optimal supply chain configuration. Our results show that our proposed approach can easily be adapted to the practices in semiconductor supply chain, and the solution methodology developed in this paper is truly promising.
Background: Glioblastoma is an aggressive brain cancer, usually of unknown etiology, and with a very poor prognosis. Survival from diagnosis averages only 3 months if left untreated and this only increases to 12–15 months upon treatment. Treatment options are currently limited and typically comprise radiotherapy plus a course of the DNA-alkylating chemotherapeutic temozolomide. Unfortunately, the disease invariably relapses after several months of treatment with temozolomide, due to the development of resistance to the drug. Increased local tryptophan metabolism is a feature of many solid malignant tumours through increased expression of tryptophan metabolising enzymes. Glioblastomas are notable for featuring increased expression of the tryptophan catabolizing enzymes indole-2,3-dioxygenase-1 (IDO1), and especially tryptophan-2,3-dioxygenase-2 (TDO2). Increased IDO1 and TDO2 activity is known to suppress the cytotoxic T cell response to tumour cells, and this has led to the proposal that the IDO1 and TDO2 enzymes represent promising immuno-oncology targets. In addition to immune modulation, however, recent studies have also identified the activity of these enzymes is important in the development of resistance to chemotherapeutic agents. Methods: In the current study, the efficacy of a novel dual inhibitor of IDO1 and TDO2, AT-0174, was assessed in an orthotopic mouse model of glioblastoma. C57BL/6J mice were stereotaxically implanted with GL261(luc2) cells into the striatum and then administered either vehicle control, temozolomide (8 mg/kg IP; five 8-day cycles of treatment every 2 days), AT-0174 (120 mg/kg/day PO) or both temozolomide + AT-0174, all given from day 7 after implantation. Results: Temozolomide decreased tumour growth and improved median survival but increased the infiltration of CD4+ Tregs. AT-0174 had no significant effect on tumour growth or survival when given alone, but provided clear synergy in combination with temozolomide, further decreasing tumour growth and significantly improving survival, as well as elevating CD8+ T cell expression and decreasing CD4+ Treg infiltration. Conclusion: AT-0174 exhibited an ideal profile for adjunct treatment of glioblastomas with the first-line chemotherapeutic drug temozolomide to prevent development of CD4+ Treg-mediated chemoresistance.
1 January 2020 in Chaos: An Interdisciplinary Journal of Nonlinear Science
Nonlinear dynamical systems often generate significant amounts of observational data such as time series, as well as high-dimensional spatial data. To delineate recurrence dynamics in the spatial data, prior efforts either extended the recurrence plot, which is a widely used tool for time series, to a four-dimensional hyperspace or utilized the network approach for recurrence analysis. However, very little has been done to differentiate heterogeneous types of recurrences in the spatial data (e.g., recurrence variations of state transitions in the spatial domain). Therefore, we propose a novel heterogeneous recurrence approach for spatial data analysis. First, spatial data are traversed with the Hilbert Space-Filling Curve to transform the variations of recurrence patterns from the spatial domain to the state-space domain. Second, we design an Iterated Function System to derive the fractal representation for the state-space trajectory of spatial data. Such a fractal representation effectively captures self-similar behaviors of recurrence variations and multi-state transitions in the spatial data. Third, we develop the Heterogeneous Recurrence Quantification Analysis of spatial data. Experimental results in both simulation and real-world case studies show that the proposed approach yields superior performance in the extraction of salient features to characterize and quantify heterogeneous recurrence dynamics in spatial data.